{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-079176","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2026-07-17T20:15:14+00:00","discovered_at":"2026-07-17T20:16:00.773827+00:00","generated_at":"2026-07-17T20:16:12.098558+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cadrenal Therapeutics CMO James J. Ferguson III resigns effective July 31, 2026","bullets":["CMO James J. Ferguson III resigned; effective July 31, 2026.","Company is conducting a search for replacement.","Separation agreement includes salary through separation date and COBRA premium payments for 6 months.","Agreement includes general release of claims and non-disparagement clause."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-079176","json":"https://secwatch.observer/filing/0001213900-26-079176.json","markdown":"https://secwatch.observer/filing/0001213900-26-079176.md","text":"https://secwatch.observer/filing/0001213900-26-079176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026079176/0001213900-26-079176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026079176/ea0298082-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:16:12.098558+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}